Structural Characteristics and Anti-inflammatory Activities of Chemically Sulfated-hyaluronic Acid from Streptococcus dysgalactiae
![]() |
Hong, Chang-Il
(Department of Life Science and Biotechnology, Soonchunhyang University)
Jung, Eui-Gil (Department of Life Science and Biotechnology, Soonchunhyang University) Han, Kook-Il (Department of Life Science and Biotechnology, Soonchunhyang University) Kim, Yong Hyun (BMI Korea Co. Ltd.) Lee, Sung Hee (BMI Korea Co. Ltd.) Lee, Hong Sub (Laboratory of Microbiology, Il-dong Pharmaceutical Co. Ltd.) Han, Man-Deuk (Department of Life Science and Biotechnology, Soonchunhyang University) |
1 | Alkrad, J. A., Mrestani, Y., Stroehl, D., Wartewig, S. and Neubert, R. 2003. Characterization of enzymatically digested hyaluronic acid using NMR, Raman, IR, and UV-Vis spectroscopes. J. Pharmaceut. Biomed. 31, 545-550. DOI |
2 | Allison, D. D. and Grande-Allen, K. J. 2006. Review. Hyaluronan: a powerful tissue engineering tool. J. Tissue Eng. 12, 2131-2140. DOI |
3 | Bernanke, D. H. and Orkin, R. W. 1984. Hyaluronidase activity in embryonic chick heart muscle and cushion tissues and cells. J. Dev. Biol. 106, 351-359. DOI |
4 | Boeriu, C. G., Springer, J., Kooy, F. K., van den Broek, L. A. M. and Eggink, G. 2013. Production methods for hyaluronan. J. Carbohydr. Chem. 2013, 14. |
5 | Burdick, J. A. and Prestwich, G. D. 2011. Hyaluronic acid hydrogels for biomedical applications. J. Adv. Mater. 23, 41-56. DOI |
6 | Celec, P. 2004. Nuclear factor kappa B-molecular biomedicine: the next generation. Biomed. Pharmacother. 58, 365-371. DOI |
7 | Choi, C. Y., Park, J. K., Kim, W. S., Jang, M. K. and Nah, J. W. 2011. Preparation and characterization of deoxycholic acid-grafted hyaluronic acid as a drug carrier. Polym. Korea. 35, 119-123. |
8 | Condie, R. C. and Prestwich, G. D. 2010. Engineering clinically useful hyaluronan matrices. In: Vernon, B. (ed.), Injectable Biomaterials: Science and application. Woodhead Publishing Limited: London, United Kingdom. |
9 | Duerksen-Hughes, P. J., Day, D. B., Laster, S. M., Zachariades, N. A., Aquino, L. and Gooding, L. R. 1992. Both tumor necrosis factor and nitric oxide participate in lysis of simian virus 40-transformed cells by activated macrophages. J. Immunol. 149, 2114-2122. |
10 | Fraser, J. R., Laurent, T. C. and Laurent, U. B., 1997. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 242, 27-33. DOI |
11 | Girish, K. S. and Kemparaju, K. 2007. The magic glue hyaluronan and its eraser hyaluronidase a biological overview. J. Life Sci. 80, 1921-1943. DOI |
12 | Kuo, J. W. 2006. Practical aspects of hyaluronan based medical products. pp. 217. CRC Press/Taylor & Francis Group: Boca Raton, FL, United States. |
13 | Han, M. D., Han, Y. S., Hyun, S. H. and Shin, H. W. 2008. Solubilization of water-insoluble beta-glucan isolated from Ganoderma lucidum. J. Environ. Biol. 29, 237-42. |
14 | Hiro, D., Ito, A., Matsuta, K. and Mori, Y. 1986. Hyaluronic acid is an endogenous inducer of interleukin-l production by human monocytes and rabbit macrophages. Biochem. Biophys. Res. Commun. 140, 715-722. DOI |
15 | Hwang, S. G., Yang, A. N., Kim, S. J., Kim, M. K., Oh, H. J., Lee J. D., Lee, E. J., Nam, K. W. and Han, M. D. 2014. Screening of hyaluronidase inhibitor in Korean medicinal plants. J. Life Sci. 24, 498-504. DOI |
16 | Kuo, J. W. and Prestwich, G. D. 2010. Hyaluronic acid. pp. 239-259 In: Ducheyne, P., Healy, K., Hutmacher, D., Kirkpatrick, J. (eds), Comprehensive biomaterials. Elsevier Publishers: Amsterdam, Netherlands. |
17 | Laurent, T. C. and Fraser, J. R. 1986. The properties and turnover of hyaluronan. Ciba Found. Symp. 124, 9-29. |
18 | Laurent, T. C. and Fraser, J. R. 1992. Hyaluronan. FASEB J. 6, 2397-2404. |
19 | Lim, H. R. and Shin, S. W. 2010. Effects of the essential oil components from Ligusticum chuanxiong on proinflammatory mediators of RAW264.7 macrophage cells. Nat. Prod. Sci. 16, 259-264. |
20 | Liu, L., Liu, Y., Li, J., Du, G. and Chen, J. 2011. Microbial production of hyaluronic acid: current state, challenges, and perspectives. Microb. Cell Fact. 10, 99. DOI |
21 | Locksley, R. M., Killeen, N. and Lenardo, M. J. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501. DOI |
22 | Park, S. G., Jegal, K. H., Jung, J. Y., Back, Y. D. Byun, S. H., Kim, Y. W., Cho, I. J., Park, S. M. and Kim, S. C. 2014. Leonuri Fructus ameliorates acute inflammation via the inhibition of NF-κB-mediated nitric oxide and pro-inflammatory cytokine production. Kor. J. Orient. Physiol. Pathol. 28,178-185. |
23 | Masters, S. L., Simon, A. Aksentijevich, I. and Kastner, D. L. 2009. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 27, 621-668. DOI |
24 | Mosmann, T. 1985. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 65, 55-63. |
25 | Park, H. S., Kim, A. R. and Noh, I. 2013. Physical and biological evaluations of cross-linked hyaluronic acid film. Biomater. Res. 17, 153-159. |
26 | Prestwich, G. D. 2007. Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J. Cell. Biochem. 101, 1370-1383. DOI |
27 | Prestwich, G. D. and Kuo, J. W. 2008. Chemically-modified HA for therapy and regenerative medicine. Curr. Pharm. Biotechnol. 9, 242-245. DOI |
28 | Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G. and Schwarz, E. M. 2003. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 111, 821-831. DOI |
29 | Ruggiero, S. L., Bertolami, C. N., Bronson, R. E. and Damiani, P. J. 1987. Hyaluronidase activity of rabbit skin wound granulation tissue fibroblasts. J. Dent. Res. 66, 1283-1287. DOI |
30 | Shiedlin, A., Bigelow, R., Christopher, W. Arbabi S, Yang, L., Maier, R. V., Wainwright, N., Childs, A. and Miller, R. J. 2004. Evaluation of hyaluronan from different sources: streptococcus zooepidemicus, rooster comb, bovine vitreous, and human umbilical cord. Biomacromolecules 5, 2122-2127. DOI |
31 | Shu, X. Z. and Prestwich, G. D. 2001. Therapeutic Biomaterials from Chemically Modified Hyaluronan. pp. 475-504. In: Hales, C. A. (ed.), Chemistry and Biology of Hyaluronan. Woodhead Publishing Limited: London, United Kingdom. |
32 | Toole, B. P. 2001. Hyaluronan in morphogenesis. Semin. Cell Dev. Biol. 12, 79-87. DOI |
33 | Toole, B. P. 2004. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528-539. DOI |
34 | Wang, S., Chen, Y., He, D., Yang, Y., Chen, J. and Wang, X. 2007. Inhibition of vascular smooth muscle cell proliferation by serum from rats treated orally with Gastrodia and Uncaria decoction, a traditional Chinese formulation. J. Ethnopharmacol. 114, 458-462. DOI |
35 | Weiss, C. 1998. Viscoseparation and viscoprotection as therapeutic modalities in the musculoskeletal system. pp. 255-266. In: Laurent, T. C. (ed.) The chemistry, biology and medical applications of hyaluronan and its derivatives. Woodhead Publishing Limited: London, The United Kingdom. |
36 | West, D. C., Hampson, I. N., Arnold, F. and Kumar, S. 1985. Angiogenesis induced by degradation products of hyaluronic acid. Science 228, 1324-1328. DOI |
37 | Yun, H. Y., Dawson, V. L. and Dawson, T. M. 1996. Neurobiology of nitric oxide. Crit. Rev. Neurobiol. 10, 291-316. DOI |
![]() |